123 filings
Page 3 of 7
8-K
6fdm28fh7lhhr
12 Nov 20
Salarius Pharmaceuticals Reports Business Highlights and Third Quarter 2020 Financial Results
8:01am
8-K
tn54j8dx
6 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
gnyp7iw16k 3392rx4sw
12 Aug 20
Salarius Pharmaceuticals Reports Business Highlights and Second Quarter 2020 Financial Results
4:10pm
8-K
nqd78kh
3 Aug 20
Salarius Announces Pricing of $5.3 Million Underwritten Public Offering
4:29pm
8-K
o8nwparioxg00myxva
29 Jul 20
Salarius Announces Proposed Public Offering of Common Stock
4:34pm
8-K
tj7rsu8d
19 Jun 20
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
ucrdl2
18 Jun 20
Other Events
4:34pm
8-K
5a3y6qn55zlj956uld
14 May 20
Salarius Pharmaceuticals Reports First Quarter 2020 Financial Results
4:09pm
8-K
mtg522 eo3l8wg21
29 Apr 20
Departure of Directors or Certain Officers
4:31pm
8-K
atqoh0a
10 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:14pm
8-K
6i0rxqac5krv
27 Mar 20
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
4:35pm
8-K
clsmt k55q9d6c
11 Mar 20
Other Events
4:28pm
8-K
xgmq z8ukeogqr
12 Feb 20
Salarius Announces Pricing of $9.6 Million Underwritten Public Offering
5:14pm
8-K
bu306dbd
28 Oct 19
Salarius Pharmaceuticals and Aspire Capital Announce a $10.9M Common Stock Purchase Agreement
8:01am
8-K
9xt5lg2 h5p2tf7
22 Oct 19
Submission of Matters to a Vote of Security Holders
4:22pm
8-K/A
hnuq6kf43292qass83cj
18 Sep 19
Index to Financial Statements
4:55pm
8-K
ee3kte5itlbpu132nzb
16 Sep 19
Departure of Directors or Certain Officers
5:15pm
8-K
0ku51g a9avi
12 Aug 19
Regulation FD Disclosure
8:16am
8-K
26f5mxm7cnrpr cf
24 Jul 19
Entry into a Material Definitive Agreement
4:48pm
8-K
bxrulp2xb 6txonv
22 Jul 19
Salarius Pharmaceuticals Announces Closing of Strategic Merger
5:08pm